Publications

Journal Article Ppublish

PubMed: 40120941 DOI: 10.1016/j.virs.2025.03.005

Virus profiling of bronchoalveolar lavage fluid in hospitalized non-COVID-19 adult patients with pulmonary infection from November 2020 to November 2021.

Virol Sin 40(2):166-175

Authors: Liangyu Li, Haiyue Zhang, Pei Xiong, Chan Liu, Lu Wan, Mengling Liu, Jieyu Mao, Ruiyun Li, Min Shang, Hailing Liu, Yuchuan Luo, Jing Yin, Xiaojun Wu, Jianjun Chen

Affiliations

  • Department of Pulmonary and Critical Care Medicine, Renmin Hospital of Wuhan University, Wuhan, 430060, China.
  • Department of Respiratory and Critical Care Medicine, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai, 200433, China.
  • Tianjin University, Jinnan Hospital, Department of Respiratory and Critical Care Medicine, Tianjin, 200350, China.
  • Department of Pulmonary and Critical Care Medicine, Renmin Hospital of Wuhan University, Wuhan, 430060, China.
  • Key Laboratory of Special Pathogens and Biosafety, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, 430071, China.

Abstract

Identifying the cause of respiratory tract infections is important for reducing the burden of diagnosis and treatment. To assess viral etiologies of hospitalized patients with pulmonary infection, bronchoalveolar lavage fluid (BALF) specimens were collected from non-COVID-19 adult patients (n ​= ​333, including patients with lower respiratory tract infection, tuberculosis, lung cancer, and pulmonary nodules) between November 2020 and November 2021. Multiple common respiratory pathogens were detected using multiplex reverse-transcription polymerase chain reaction. The result showed that at least one virus was identified in 35.44% (118/333) of the cases. Among these, influenza virus was the most commonly identified, followed by the parainfluenza virus, coronavirus, human rhinoviruses, and human respiratory syncytial viruses. The tuberculosis group demonstrated the highest viral detection rate, yet paradoxically exhibited the lowest co-infection rate. In contrast, the highest co-infection frequency was observed in the pulmonary nodules group. Patients with viral infections exhibited more severe clinical symptoms compared to those without detected viral infections. However, this observation was only noted in the lower respiratory tract infection group among the different disease groups. Notably, among patients infected with a specific virus, there were no significant differences in viral load between single and co-infections. Our study identified the major causative agents in hospitalized adult patients with pulmonary infection, offering insights for precise disease diagnosis and the prevention of unnecessary use of antimicrobial drugs.

MeSH

Bronchoalveolar Lavage, Virology, Coinfection, Respiratory Tract Infections, Bronchoalveolar Lavage Fluid, Signs And Symptoms, Covid-19, Influenza, Human, Tuberculosis, Viruses, Diagnosis, Orthomyxoviridae, Infections, Virus Diseases